Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20
Apr 25
Singaporean (SGX) Pharma Industry Analysis
UpdatedMay 05, 2024
DataAggregated Company Financials
Companies4
- 7D-1.5%
- 3M0.3%
- 1Y-0.9%
- YTDn/a
Over the last 7 days, the Pharma industry has remained flat, although notably iX Biopharma gained 12%. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the Singaporean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 05 May 2024 | S$2.3b | S$417.2m | S$214.6m | 9.9x | 10.5x | 5.4x |
| Tue, 02 Apr 2024 | S$2.3b | S$417.2m | S$214.6m | 9.9x | 10.6x | 5.5x |
| Thu, 29 Feb 2024 | S$2.3b | S$419.8m | S$215.3m | 10.3x | 10.8x | 5.6x |
| Sat, 27 Jan 2024 | S$2.2b | S$371.1m | S$172.1m | 12.6x | 13x | 6x |
| Mon, 25 Dec 2023 | S$2.2b | S$371.0m | S$172.1m | 12.6x | 13x | 6x |
| Wed, 22 Nov 2023 | S$5.4b | S$1.6b | S$310.9m | 12.5x | 17.4x | 3.5x |
| Fri, 20 Oct 2023 | S$5.0b | S$1.5b | S$326.6m | 9.9x | 15.4x | 3.3x |
| Sun, 17 Sep 2023 | S$5.4b | S$1.5b | S$327.4m | 10.2x | 16.5x | 3.5x |
| Tue, 15 Aug 2023 | S$5.9b | S$1.5b | S$314.2m | 10.9x | 18.7x | 3.8x |
| Thu, 13 Jul 2023 | S$5.8b | S$1.5b | S$289.4m | 9.9x | 19.9x | 3.7x |
| Sat, 10 Jun 2023 | S$6.5b | S$1.5b | S$290.6m | 10.8x | 22.2x | 4.2x |
| Mon, 08 May 2023 | S$6.9b | S$1.6b | S$297.2m | 11.2x | 23.1x | 4.3x |
| Wed, 05 Apr 2023 | S$6.2b | S$1.6b | S$268.6m | 11.3x | 23x | 4x |
| Fri, 03 Mar 2023 | S$5.6b | S$1.4b | S$264.9m | 9.5x | 21.1x | 4x |
| Sun, 29 Jan 2023 | S$5.3b | S$1.4b | S$264.5m | 8.7x | 19.9x | 3.8x |
| Tue, 27 Dec 2022 | S$4.8b | S$1.4b | S$261.3m | 8.3x | 18.4x | 3.5x |
| Thu, 24 Nov 2022 | S$5.0b | S$1.3b | S$258.4m | 7.9x | 19.3x | 3.7x |
| Sat, 22 Oct 2022 | S$4.4b | S$1.3b | S$245.6m | 9.9x | 17.7x | 3.3x |
| Mon, 19 Sep 2022 | S$4.8b | S$1.3b | S$249.0m | 10.5x | 19.1x | 3.5x |
| Wed, 17 Aug 2022 | S$4.9b | S$1.4b | S$255.4m | 11x | 19.2x | 3.6x |
| Fri, 15 Jul 2022 | S$4.9b | S$1.3b | S$229.0m | 10x | 21.4x | 3.7x |
| Sun, 12 Jun 2022 | S$4.8b | S$1.3b | S$229.2m | 10.5x | 21.1x | 3.6x |
| Tue, 10 May 2022 | S$4.7b | S$1.3b | S$228.8m | 11.1x | 20.5x | 3.5x |
| Thu, 07 Apr 2022 | S$5.4b | S$1.4b | S$236.3m | 11.9x | 22.9x | 3.9x |
| Sat, 05 Mar 2022 | S$5.5b | S$1.4b | S$249.4m | 12.2x | 21.9x | 3.9x |
| Mon, 31 Jan 2022 | S$5.3b | S$1.3b | S$212.5m | 14.1x | 25.1x | 4x |
| Wed, 29 Dec 2021 | S$5.6b | S$1.3b | S$212.3m | 14.1x | 26.3x | 4.2x |
| Fri, 26 Nov 2021 | S$5.5b | S$1.3b | S$211.9m | 13.8x | 25.8x | 4.1x |
| Sun, 24 Oct 2021 | S$5.6b | S$1.3b | S$204.6m | 14.3x | 27.4x | 4.2x |
| Tue, 21 Sep 2021 | S$5.4b | S$1.3b | S$203.1m | 14.1x | 26.7x | 4.1x |
| Thu, 19 Aug 2021 | S$6.1b | S$1.3b | S$203.2m | 23.2x | 30x | 4.6x |
| Thu, 03 Jun 2021 | S$5.7b | S$1.3b | S$205.8m | 23.3x | 27.9x | 4.5x |
Price to Earnings Ratio
27.9x
Current Industry PE
- Investors are pessimistic on the Singaporean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 10.7x which is lower than its 3-year average PE of 20.8x.
- The 3-year average PS ratio of 4.2x is lower than the industry's current PS ratio of 5.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have declined 31% per year.
- This means that the cost of doing business could be reducing since sales have declined but profits have remained steady.
Industry Comparison
How does Singaporean Pharma compare with similar industries?
| SG Market | 0.041% | |
| Healthcare | -1.01% | |
| Pharma | -1.51% | |
| Pharma | -1.51% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 42C iX Biopharma | S$0.047 | 11.9% +S$3.8m | -47.8% | PS6x | |
| 1J5 Hyphens Pharma International | S$0.28 | 1.9% +S$1.5m | -17.9% | PE9.9x |